Yi-Long Wu
MD
Professor of Thoracic Oncology
👥Biography 个人简介
Yi-Long Wu directed the ADJUVANT-CTONG1104 and EVIDENCE trials demonstrating adjuvant gefitinib and icotinib benefit in Asian EGFR-mutant NSCLC, preceding and informing ADAURA. He was a lead Asian site investigator for ADAURA and shaped adoption of adjuvant osimertinib across Asia. His work addresses the high EGFR mutation prevalence in East Asian populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Yi-Long Wu 的研究动态
Follow Yi-Long Wu's research updates
留下邮箱，当我们发布与 Yi-Long Wu（Guangdong Provincial People's Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment